Thus, it would seem that inhibition of FABP4 function may be therapeutic for numerous prevalent diseases including diabetes, cancer, and atherosclerosis, and numerous small molecule inhibitors have been developed (44). This evidence concerns the gene FABP4 and atherosclerosis.